Phase III Oncology

 Liver tumours

Room 2
English
Abstract session
28 August 2020 15:30 - 17:00


Presentations

Title Time

Add to Calendar

LBO09 A phase 1b study of lenvatinib plus pembrolizumab in unresectable hepatocellular carcinoma
28 August 2020 15:30 - 15:45
LBO10 Atezolizumab + bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma: safety results from the Phase III IMbrave150 study
28 August 2020 15:45 - 16:00
LBO11 Nivolumab + ipilimumab combination therapy in patients with advanced hepatocellular carcinoma: subgroup analyses from CheckMate 040
28 August 2020 16:00 - 16:15
LBO12 Data from the third dose cohort of an ongoing study with ADP-A2AFP SPEAR T cells
28 August 2020 16:15 - 16:30